These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
190 related items for PubMed ID: 12067227
1. The degenerative effect of a single intranigral injection of LPS on the dopaminergic system is prevented by dexamethasone, and not mimicked by rh-TNF-alpha, IL-1beta and IFN-gamma. Castaño A, Herrera AJ, Cano J, Machado A. J Neurochem; 2002 Apr; 81(1):150-7. PubMed ID: 12067227 [Abstract] [Full Text] [Related]
2. Thrombin induces in vivo degeneration of nigral dopaminergic neurones along with the activation of microglia. Carreño-Müller E, Herrera AJ, de Pablos RM, Tomás-Camardiel M, Venero JL, Cano J, Machado A. J Neurochem; 2003 Mar; 84(5):1201-14. PubMed ID: 12603843 [Abstract] [Full Text] [Related]
3. Somatostatin prevents lipopolysaccharide-induced neurodegeneration in the rat substantia nigra by inhibiting the activation of microglia. Bai L, Zhang X, Li X, Liu N, Lou F, Ma H, Luo X, Ren Y. Mol Med Rep; 2015 Jul; 12(1):1002-8. PubMed ID: 25777539 [Abstract] [Full Text] [Related]
4. Triptolide protects dopaminergic neurons from inflammation-mediated damage induced by lipopolysaccharide intranigral injection. Zhou HF, Liu XY, Niu DB, Li FQ, He QH, Wang XM. Neurobiol Dis; 2005 Apr; 18(3):441-9. PubMed ID: 15755670 [Abstract] [Full Text] [Related]
5. Curcumin protects dopaminergic neurons against inflammation-mediated damage and improves motor dysfunction induced by single intranigral lipopolysaccharide injection. Sharma N, Sharma S, Nehru B. Inflammopharmacology; 2017 Jun; 25(3):351-368. PubMed ID: 28409389 [Abstract] [Full Text] [Related]
6. Glucocorticoid receptor is involved in the neuroprotective effect of ginsenoside Rg1 against inflammation-induced dopaminergic neuronal degeneration in substantia nigra. Sun XC, Ren XF, Chen L, Gao XQ, Xie JX, Chen WF. J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt A):94-103. PubMed ID: 26455404 [Abstract] [Full Text] [Related]
7. Dopamine-dependent neurotoxicity of lipopolysaccharide in substantia nigra. De Pablos RM, Herrera AJ, Villarán RF, Cano J, Machado A. FASEB J; 2005 Mar; 19(3):407-9. PubMed ID: 15625078 [Abstract] [Full Text] [Related]
9. Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation. Liu B, Du L, Hong JS. J Pharmacol Exp Ther; 2000 May; 293(2):607-17. PubMed ID: 10773035 [Abstract] [Full Text] [Related]
10. Potential of the cannabinoid CB(2) receptor as a pharmacological target against inflammation in Parkinson's disease. Gómez-Gálvez Y, Palomo-Garo C, Fernández-Ruiz J, García C. Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan 04; 64():200-8. PubMed ID: 25863279 [Abstract] [Full Text] [Related]
11. Inflammatory process as a determinant factor for the degeneration of substantia nigra dopaminergic neurons. Herrera AJ, Tomás-Camardiel M, Venero JL, Cano J, Machado A. J Neural Transm (Vienna); 2005 Jan 04; 112(1):111-9. PubMed ID: 15599609 [Abstract] [Full Text] [Related]
12. Degeneration of dopaminergic neurons induced by thrombin injection in the substantia nigra of the rat is enhanced by dexamethasone: role of monoamine oxidase enzyme. Argüelles S, Herrera AJ, Carreño-Müller E, de Pablos RM, Villarán RF, Espinosa-Oliva AM, Machado A, Cano J. Neurotoxicology; 2010 Jan 04; 31(1):55-66. PubMed ID: 19969022 [Abstract] [Full Text] [Related]
13. Neurotoxic effects of lipopolysaccharide on nigral dopaminergic neurons are mediated by microglial activation, interleukin-1beta, and expression of caspase-11 in mice. Arai H, Furuya T, Yasuda T, Miura M, Mizuno Y, Mochizuki H. J Biol Chem; 2004 Dec 03; 279(49):51647-53. PubMed ID: 15383538 [Abstract] [Full Text] [Related]
14. Differential Effects of LPS and 6-OHDA on Microglia's Morphology in Rats: Implications for Inflammatory Model of Parkinson's Disease. Parra I, Martínez I, Ramírez-García G, Tizabi Y, Mendieta L. Neurotox Res; 2020 Jan 03; 37(1):1-11. PubMed ID: 31478124 [Abstract] [Full Text] [Related]
15. Peripheral inflammation increases the deleterious effect of CNS inflammation on the nigrostriatal dopaminergic system. Hernández-Romero MC, Delgado-Cortés MJ, Sarmiento M, de Pablos RM, Espinosa-Oliva AM, Argüelles S, Bández MJ, Villarán RF, Mauriño R, Santiago M, Venero JL, Herrera AJ, Cano J, Machado A. Neurotoxicology; 2012 Jun 03; 33(3):347-60. PubMed ID: 22330755 [Abstract] [Full Text] [Related]
16. Anti-inflammatory effects of BHBA in both in vivo and in vitro Parkinson's disease models are mediated by GPR109A-dependent mechanisms. Fu SP, Wang JF, Xue WJ, Liu HM, Liu BR, Zeng YL, Li SN, Huang BX, Lv QK, Wang W, Liu JX. J Neuroinflammation; 2015 Jan 17; 12():9. PubMed ID: 25595674 [Abstract] [Full Text] [Related]
19. Microglia-Derived Cytokines/Chemokines Are Involved in the Enhancement of LPS-Induced Loss of Nigrostriatal Dopaminergic Neurons in DJ-1 Knockout Mice. Chien CH, Lee MJ, Liou HC, Liou HH, Fu WM. PLoS One; 2016 Jan 17; 11(3):e0151569. PubMed ID: 26982707 [Abstract] [Full Text] [Related]